UK strikes pact for 60 million doses of COVID-19 experimental vaccine
Published 30 Jul, 2020
By Staff Reporter
The UK government on Wednesday announced an early access agreement with GlaxoSmithKline (GSK) and Sanofi Pasteur for an estimated 60 million doses of an experimental new vaccine being tested to combat COVID-19.